カテゴリー： QYResearch, 世界

世界の線維芽細胞増殖因子受容体4市場 2019年

【英語タイトル】Global Fibroblast Growth Factor Receptor 4 Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X07728）・商品コード：DATA909X07728
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、線維芽細胞増殖因子受容体4の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BLU-9931、BMS-986036、エルダフィチニブ、ES-135、FGF-401、その他に、用途別には、乳癌、リンパ腫、黒色腫、卵管癌、肺癌、その他にセグメント区分し、線維芽細胞増殖因子受容体4の世界市場を分析しました。


・エグゼクティブ・サマリー
・線維芽細胞増殖因子受容体4の世界市場概要
・線維芽細胞増殖因子受容体4の製造コスト構成分析
・線維芽細胞増殖因子受容体4の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・線維芽細胞増殖因子受容体4の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・線維芽細胞増殖因子受容体4のセグメント分析（種類別）
（BLU-9931、BMS-986036、エルダフィチニブ、ES-135、FGF-401、その他）
・線維芽細胞増殖因子受容体4のセグメント分析（用途別）
（乳癌、リンパ腫、黒色腫、卵管癌、肺癌、その他）
・線維芽細胞増殖因子受容体4の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Amgen Inc、ArQule Inc、AstraZeneca Plc、Blueprint Medicines Corp、Bristol-Myers Squibb Co、Eisai Co Ltd、Eli Lilly and Co、Genosco Inc、H3 Biomedicine Inc、Incyte Corp、Ionis Pharmaceuticals Inc、Johnson & Johnson、Merrimack Pharmaceuticals Inc、NGM Biopharmaceuticals Inc、Novartis AG、Principia Biopharma Inc、Tasly Pharmaceutical Group Co Ltd、Vichem Chemie Research Ltd、）
・線維芽細胞増殖因子受容体4の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Fibroblast Growth Factor Receptor 4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Fibroblast Growth Factor Receptor 4 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fibroblast Growth Factor Receptor 4 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fibroblast Growth Factor Receptor 4 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fibroblast Growth Factor Receptor 4 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen Inc
ArQule Inc
AstraZeneca Plc
Blueprint Medicines Corp
Bristol-Myers Squibb Co
Eisai Co Ltd
Eli Lilly and Co
Genosco Inc
H3 Biomedicine Inc
Incyte Corp
Ionis Pharmaceuticals Inc
Johnson & Johnson
Merrimack Pharmaceuticals Inc
NGM Biopharmaceuticals Inc
Novartis AG
Principia Biopharma Inc
Tasly Pharmaceutical Group Co Ltd
Vichem Chemie Research Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
BLU-9931
BMS-986036
Erdafitinib
ES-135
FGF-401
Others

Segment by Application
Breast Cancer
Lymphoma
Melanoma
Fallopian Tube Cancer
Lung Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Fibroblast Growth Factor Receptor 4
1.1 Definition of Fibroblast Growth Factor Receptor 4
1.2 Fibroblast Growth Factor Receptor 4 Segment by Type
1.2.1 Global Fibroblast Growth Factor Receptor 4 Production Growth Rate Comparison by Types (2014-2025)
1.2.2 BLU-9931
1.2.3 BMS-986036
1.2.4 Erdafitinib
1.2.5 ES-135
1.2.6 FGF-401
1.2.7 Others
1.3 Fibroblast Growth Factor Receptor 4 Segment by Applications
1.3.1 Global Fibroblast Growth Factor Receptor 4 Consumption Comparison by Applications (2014-2025)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.3.4 Melanoma
1.3.5 Fallopian Tube Cancer
1.3.6 Lung Cancer
1.3.7 Others
1.4 Global Fibroblast Growth Factor Receptor 4 Overall Market
1.4.1 Global Fibroblast Growth Factor Receptor 4 Revenue (2014-2025)
1.4.2 Global Fibroblast Growth Factor Receptor 4 Production (2014-2025)
1.4.3 North America Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
1.4.4 Europe Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
1.4.5 China Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
1.4.6 Japan Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
1.4.7 Southeast Asia Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
1.4.8 India Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Fibroblast Growth Factor Receptor 4
2.3 Manufacturing Process Analysis of Fibroblast Growth Factor Receptor 4
2.4 Industry Chain Structure of Fibroblast Growth Factor Receptor 4

3 Development and Manufacturing Plants Analysis of Fibroblast Growth Factor Receptor 4
3.1 Capacity and Commercial Production Date
3.2 Global Fibroblast Growth Factor Receptor 4 Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Fibroblast Growth Factor Receptor 4
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Fibroblast Growth Factor Receptor 4 Production and Capacity Analysis
4.2 Fibroblast Growth Factor Receptor 4 Revenue Analysis
4.3 Fibroblast Growth Factor Receptor 4 Price Analysis
4.4 Market Concentration Degree

5 Fibroblast Growth Factor Receptor 4 Regional Market Analysis
5.1 Fibroblast Growth Factor Receptor 4 Production by Regions
5.1.1 Global Fibroblast Growth Factor Receptor 4 Production by Regions
5.1.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Regions
5.2 Fibroblast Growth Factor Receptor 4 Consumption by Regions
5.3 North America Fibroblast Growth Factor Receptor 4 Market Analysis
5.3.1 North America Fibroblast Growth Factor Receptor 4 Production
5.3.2 North America Fibroblast Growth Factor Receptor 4 Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Fibroblast Growth Factor Receptor 4 Import and Export
5.4 Europe Fibroblast Growth Factor Receptor 4 Market Analysis
5.4.1 Europe Fibroblast Growth Factor Receptor 4 Production
5.4.2 Europe Fibroblast Growth Factor Receptor 4 Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Fibroblast Growth Factor Receptor 4 Import and Export
5.5 China Fibroblast Growth Factor Receptor 4 Market Analysis
5.5.1 China Fibroblast Growth Factor Receptor 4 Production
5.5.2 China Fibroblast Growth Factor Receptor 4 Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Fibroblast Growth Factor Receptor 4 Import and Export
5.6 Japan Fibroblast Growth Factor Receptor 4 Market Analysis
5.6.1 Japan Fibroblast Growth Factor Receptor 4 Production
5.6.2 Japan Fibroblast Growth Factor Receptor 4 Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Fibroblast Growth Factor Receptor 4 Import and Export
5.7 Southeast Asia Fibroblast Growth Factor Receptor 4 Market Analysis
5.7.1 Southeast Asia Fibroblast Growth Factor Receptor 4 Production
5.7.2 Southeast Asia Fibroblast Growth Factor Receptor 4 Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Fibroblast Growth Factor Receptor 4 Import and Export
5.8 India Fibroblast Growth Factor Receptor 4 Market Analysis
5.8.1 India Fibroblast Growth Factor Receptor 4 Production
5.8.2 India Fibroblast Growth Factor Receptor 4 Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Fibroblast Growth Factor Receptor 4 Import and Export

6 Fibroblast Growth Factor Receptor 4 Segment Market Analysis (by Type)
6.1 Global Fibroblast Growth Factor Receptor 4 Production by Type
6.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Type
6.3 Fibroblast Growth Factor Receptor 4 Price by Type

7 Fibroblast Growth Factor Receptor 4 Segment Market Analysis (by Application)
7.1 Global Fibroblast Growth Factor Receptor 4 Consumption by Application
7.2 Global Fibroblast Growth Factor Receptor 4 Consumption Market Share by Application (2014-2019)

8 Fibroblast Growth Factor Receptor 4 Major Manufacturers Analysis
8.1 Amgen Inc
8.1.1 Amgen Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.1.2 Amgen Inc Product Introduction, Application and Specification
8.1.3 Amgen Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 ArQule Inc
8.2.1 ArQule Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.2.2 ArQule Inc Product Introduction, Application and Specification
8.2.3 ArQule Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca Plc
8.3.1 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.3.2 AstraZeneca Plc Product Introduction, Application and Specification
8.3.3 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Blueprint Medicines Corp
8.4.1 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.4.2 Blueprint Medicines Corp Product Introduction, Application and Specification
8.4.3 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bristol-Myers Squibb Co
8.5.1 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.5.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
8.5.3 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eisai Co Ltd
8.6.1 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.6.2 Eisai Co Ltd Product Introduction, Application and Specification
8.6.3 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Eli Lilly and Co
8.7.1 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.7.2 Eli Lilly and Co Product Introduction, Application and Specification
8.7.3 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Genosco Inc
8.8.1 Genosco Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.8.2 Genosco Inc Product Introduction, Application and Specification
8.8.3 Genosco Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 H3 Biomedicine Inc
8.9.1 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.9.2 H3 Biomedicine Inc Product Introduction, Application and Specification
8.9.3 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Incyte Corp
8.10.1 Incyte Corp Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
8.10.2 Incyte Corp Product Introduction, Application and Specification
8.10.3 Incyte Corp Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Ionis Pharmaceuticals Inc
8.12 Johnson & Johnson
8.13 Merrimack Pharmaceuticals Inc
8.14 NGM Biopharmaceuticals Inc
8.15 Novartis AG
8.16 Principia Biopharma Inc
8.17 Tasly Pharmaceutical Group Co Ltd
8.18 Vichem Chemie Research Ltd

9 Development Trend of Analysis of Fibroblast Growth Factor Receptor 4 Market
9.1 Global Fibroblast Growth Factor Receptor 4 Market Trend Analysis
9.1.1 Global Fibroblast Growth Factor Receptor 4 Market Size (Volume and Value) Forecast 2019-2025
9.2 Fibroblast Growth Factor Receptor 4 Regional Market Trend
9.2.1 North America Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
9.2.2 Europe Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
9.2.3 China Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
9.2.4 Japan Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
9.2.5 Southeast Asia Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
9.2.6 India Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
9.3 Fibroblast Growth Factor Receptor 4 Market Trend (Product Type)
9.4 Fibroblast Growth Factor Receptor 4 Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Fibroblast Growth Factor Receptor 4 Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Fibroblast Growth Factor Receptor 4
Table Global Fibroblast Growth Factor Receptor 4 Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Fibroblast Growth Factor Receptor 4 Production Market Share by Types in 2018
Figure BLU-9931 Product Picture
Figure BMS-986036 Product Picture
Figure Erdafitinib Product Picture
Figure ES-135 Product Picture
Figure FGF-401 Product Picture
Figure Others Product Picture
Table Global Fibroblast Growth Factor Receptor 4 Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Fibroblast Growth Factor Receptor 4 Consumption Market Share by Applications in 2018
Figure Breast Cancer
Figure Lymphoma
Figure Melanoma
Figure Fallopian Tube Cancer
Figure Lung Cancer
Figure Others
Figure Global Fibroblast Growth Factor Receptor 4 Revenue (Million USD) (2014-2025)
Figure Global Fibroblast Growth Factor Receptor 4 Production (K Pcs) (2014-2025)
Figure North America Fibroblast Growth Factor Receptor 4 Market Size (Million USD) (2014-2025)
Figure Europe Fibroblast Growth Factor Receptor 4 Market Size (Million USD) (2014-2025)
Figure China Fibroblast Growth Factor Receptor 4 Market Size (Million USD) (2014-2025)
Figure Japan Fibroblast Growth Factor Receptor 4 Market Size (Million USD) (2014-2025)
Figure Southeast Asia Fibroblast Growth Factor Receptor 4 Market Size (Million USD) (2014-2025)
Figure India Fibroblast Growth Factor Receptor 4 Market Size (Million USD) (2014-2025)
Table Fibroblast Growth Factor Receptor 4 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Fibroblast Growth Factor Receptor 4 in 2018
Figure Manufacturing Process Analysis of Fibroblast Growth Factor Receptor 4
Figure Industry Chain Structure of Fibroblast Growth Factor Receptor 4
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Fibroblast Growth Factor Receptor 4 Manufacturing Plants Distribution
Table Fibroblast Growth Factor Receptor 4 Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Fibroblast Growth Factor Receptor 4 Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Fibroblast Growth Factor Receptor 4 Production (K Pcs) of Major Manufacturers (2014-2019)
Table Fibroblast Growth Factor Receptor 4 Production Market Share of Major Manufacturers (2014-2019)
Figure Fibroblast Growth Factor Receptor 4 Production Share by Manufacturers in 2018
Table Fibroblast Growth Factor Receptor 4 Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Fibroblast Growth Factor Receptor 4 Revenue Market Share of Major Manufacturers (2014-2019)
Figure Fibroblast Growth Factor Receptor 4 Revenue Share by Manufacturers in 2018
Table Fibroblast Growth Factor Receptor 4 Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Fibroblast Growth Factor Receptor 4 Production by Regions 2014-2019 (K Pcs)
Table Global Fibroblast Growth Factor Receptor 4 Production Market Share by Regions 2014-2019
Figure Global Fibroblast Growth Factor Receptor 4 Production Market Share by Regions in 2018
Table Global Fibroblast Growth Factor Receptor 4 Revenue by Regions 2014-2019 (Million USD)
Table Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Regions 2014-2019
Figure Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Regions in 2018
Table Global Fibroblast Growth Factor Receptor 4 Consumption by Regions 2014-2019 (K Pcs)
Table Global Fibroblast Growth Factor Receptor 4 Consumption Market Share by Regions 2014-2019
Figure North America Fibroblast Growth Factor Receptor 4 Production Growth Rate 2014-2019 (K Pcs)
Figure North America Fibroblast Growth Factor Receptor 4 Revenue Growth Rate 2014-2019 (Million USD)
Table North America Fibroblast Growth Factor Receptor 4 Production, Consumption Import and Export (K Pcs)
Figure Europe Fibroblast Growth Factor Receptor 4 Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Fibroblast Growth Factor Receptor 4 Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Fibroblast Growth Factor Receptor 4 Production, Consumption Import and Export (K Pcs)
Figure China Fibroblast Growth Factor Receptor 4 Production Growth Rate 2014-2019 (K Pcs)
Figure China Fibroblast Growth Factor Receptor 4 Revenue Growth Rate 2014-2019 (Million USD)
Table China Fibroblast Growth Factor Receptor 4 Production, Consumption Import and Export (K Pcs)
Figure Japan Fibroblast Growth Factor Receptor 4 Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Fibroblast Growth Factor Receptor 4 Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Fibroblast Growth Factor Receptor 4 Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Fibroblast Growth Factor Receptor 4 Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Fibroblast Growth Factor Receptor 4 Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Fibroblast Growth Factor Receptor 4 Production, Consumption Import and Export (K Pcs)
Figure India Fibroblast Growth Factor Receptor 4 Production Growth Rate 2014-2019 (K Pcs)
Figure India Fibroblast Growth Factor Receptor 4 Revenue Growth Rate 2014-2019 (Million USD)
Table India Fibroblast Growth Factor Receptor 4 Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Fibroblast Growth Factor Receptor 4 Market Share by Application (2014-2019)
Figure Global Value (Consumption) Fibroblast Growth Factor Receptor 4 Market Share by Application (2014-2019)
Table Amgen Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Amgen Inc Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table Amgen Inc Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table Amgen Inc Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure Amgen Inc Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table Amgen Inc Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table ArQule Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table ArQule Inc Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table ArQule Inc Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ArQule Inc Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table ArQule Inc Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure ArQule Inc Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table ArQule Inc Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table Genosco Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Genosco Inc Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table Genosco Inc Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genosco Inc Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table Genosco Inc Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure Genosco Inc Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table Genosco Inc Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table Incyte Corp Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Incyte Corp Fibroblast Growth Factor Receptor 4 Product Introduction, Application and Specification
Table Incyte Corp Fibroblast Growth Factor Receptor 4 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Incyte Corp Fibroblast Growth Factor Receptor 4 Production Growth Rate (2014-2019)
Table Incyte Corp Fibroblast Growth Factor Receptor 4 Production Market Share (2014-2019)
Figure Incyte Corp Fibroblast Growth Factor Receptor 4 Revenue Market Share (2014-2019)
Table Incyte Corp Fibroblast Growth Factor Receptor 4 Main Business and Markets Served
Table Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Johnson & Johnson Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Novartis AG Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Table Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
Figure Global Fibroblast Growth Factor Receptor 4 Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Fibroblast Growth Factor Receptor 4 Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Fibroblast Growth Factor Receptor 4 Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Fibroblast Growth Factor Receptor 4 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Fibroblast Growth Factor Receptor 4 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Fibroblast Growth Factor Receptor 4 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Fibroblast Growth Factor Receptor 4 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Fibroblast Growth Factor Receptor 4 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Fibroblast Growth Factor Receptor 4 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Fibroblast Growth Factor Receptor 4 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Fibroblast Growth Factor Receptor 4 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Fibroblast Growth Factor Receptor 4 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Fibroblast Growth Factor Receptor 4 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Fibroblast Growth Factor Receptor 4 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Fibroblast Growth Factor Receptor 4 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Fibroblast Growth Factor Receptor 4 by Type (2019-2025)
Table Global Consumption (K Pcs) of Fibroblast Growth Factor Receptor 4 by Application (2019-2025)
Table Fibroblast Growth Factor Receptor 4 Distributors List
Table Fibroblast Growth Factor Receptor 4 Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Amgen Inc、ArQule Inc、AstraZeneca Plc、Blueprint Medicines Corp、Bristol-Myers Squibb Co、Eisai Co Ltd、Eli Lilly and Co、Genosco Inc、H3 Biomedicine Inc、Incyte Corp、Ionis Pharmaceuticals Inc、Johnson & Johnson、Merrimack Pharmaceuticals Inc、NGM Biopharmaceuticals Inc、Novartis AG、Principia Biopharma Inc、Tasly Pharmaceutical Group Co Ltd、Vichem Chemie Research Ltd、

★調査レポート[世界の線維芽細胞増殖因子受容体4市場 2019年] (コード：DATA909X07728)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の線維芽細胞増殖因子受容体4市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の高親和性神経成長因子受容体市場 2019年
    DATA909X08997 / QYResearch / 2019年11月20日 / ※本調査レポートは、高親和性神経成長因子受容体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ASP-7962、AZD-7451、BNN-27、セネゲルミン、CRB-0089、その他に、用途別には、胆管癌、甲状腺乳頭癌、腰痛、肺癌、その他にセグメント区分し、高親和性神経成長因子受容体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・高親和性神経成長因子受容体の世界市場概要 ・高親和性神経成長因子受容体の製造コスト構成分析 ・高親和性神経成長因子受容体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・高親和性神経成長因子受容体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・高親和性神経成長因子受容体のセグメント分析（種類別） （ASP-7962、AZD-7451、BNN-27、セネゲルミン、CRB-0089、その他）...The global High Affinity Nerve Growth Factor Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Affinity Nerve Growth Factor Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Affinity Nerve Growth Factor Receptor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of High Affinity Nerve Growth Factor Receptor in North America, Europe, China,...
  • 世界の凝固因子濃縮物市場 2019年
    DATA909X05576 / QYResearch / 2019年11月15日 / ※本調査レポートは、凝固因子濃縮物の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、凝固因子IX、凝固因子XIII、その他に、用途別には、病院と診療所、研究所、学術機関にセグメント区分し、凝固因子濃縮物の世界市場を分析しました。 ・エグゼクティブ・サマリー ・凝固因子濃縮物の世界市場概要 ・凝固因子濃縮物の製造コスト構成分析 ・凝固因子濃縮物の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・凝固因子濃縮物の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・凝固因子濃縮物のセグメント分析（種類別） （凝固因子IX、凝固因子XIII、その他）...The global Coagulation Factor Concentrate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coagulation Factor Concentrate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coagulation Factor Concentrate market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coagulation Factor Concentrate in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のニューロペプチドY受容体タイプ2市場 2019年
    DATA909X11956 / QYResearch / 2019年11月20日 / ※本調査レポートは、ニューロペプチドY受容体タイプ2の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、XL-310、NN-9748、GT-002、その他に、用途別には、肥満、てんかん、2型糖尿病、その他にセグメント区分し、ニューロペプチドY受容体タイプ2の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ニューロペプチドY受容体タイプ2の世界市場概要 ・ニューロペプチドY受容体タイプ2の製造コスト構成分析 ・ニューロペプチドY受容体タイプ2の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ニューロペプチドY受容体タイプ2の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ニューロペプチドY受容体タイプ2のセグメント分析（種類別） （XL-310、NN-9748、GT-002、その他）...The global Neuropeptide Y Receptor Type 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neuropeptide Y Receptor Type 2 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuropeptide Y Receptor Type 2 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neuropeptide Y Receptor Type 2 in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のアリール炭化水素受容体(AhR)市場 2019年
    DATA909X03760 / QYResearch / 2019年11月15日 / ※本調査レポートは、アリール炭化水素受容体(AhR)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CB-7993113、CDR-914K058、シンナバリン酸、その他に、用途別には、肝細胞癌、多発性硬化症、肥満、骨粗鬆症、その他にセグメント区分し、アリール炭化水素受容体(AhR)の世界市場を分析しました。 ・エグゼクティブ・サマリー ・アリール炭化水素受容体(AhR)の世界市場概要 ・アリール炭化水素受容体(AhR)の製造コスト構成分析 ・アリール炭化水素受容体(AhR)の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・アリール炭化水素受容体(AhR)の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・アリール炭化水素受容体(AhR)のセグメント分析（種類別） （CB-7993113、CDR-914K058、シンナバリン酸、その他）...The global Aryl Hydrocarbon Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Aryl Hydrocarbon Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aryl Hydrocarbon Receptor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Aryl Hydrocarbon Receptor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の凝固因子市場 2019年
    DATA909X05545 / QYResearch / 2019年11月15日 / ※本調査レポートは、凝固因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他に、用途別には、病院、診療所、外来手術センターにセグメント区分し、凝固因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・凝固因子の世界市場概要 ・凝固因子の製造コスト構成分析 ・凝固因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・凝固因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・凝固因子のセグメント分析（種類別） （凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他）...The global Clotting Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Clotting Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Clotting Factor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Clotting Factor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Clotting Factor manufacturing...
  • 世界のグリア細胞株由来神経栄養因子市場 2019年
    DATA909X08492 / QYResearch / 2019年11月15日 / ※本調査レポートは、グリア細胞株由来神経栄養因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、GSK-812、LAUR-301、TW-002、AMT-090、その他に、用途別には、筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他にセグメント区分し、グリア細胞株由来神経栄養因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・グリア細胞株由来神経栄養因子の世界市場概要 ・グリア細胞株由来神経栄養因子の製造コスト構成分析 ・グリア細胞株由来神経栄養因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・グリア細胞株由来神経栄養因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・グリア細胞株由来神経栄養因子のセグメント分析（種類別） （GSK-812、LAUR-301、TW-002、AMT-090、その他）...The global Glial Cell Line Derived Neurotrophic Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glial Cell Line Derived Neurotrophic Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glial Cell Line Derived Neurotrophic Factor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Glial Cell Line Derived Neurotrophic Factor in North America, Europe, China,...
  • 世界のプロテイナーゼ活性化受容体2市場 2019年
    DATA909X13849 / QYResearch / 2019年11月20日 / ※本調査レポートは、プロテイナーゼ活性化受容体2の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、酢酸ララゾチド、AZ-8838、PZ-235、P-2pal18S、その他に、用途別には、アトピー性皮膚炎、セリアック病、膵炎、肺高血圧症、その他にセグメント区分し、プロテイナーゼ活性化受容体2の世界市場を分析しました。 ・エグゼクティブ・サマリー ・プロテイナーゼ活性化受容体2の世界市場概要 ・プロテイナーゼ活性化受容体2の製造コスト構成分析 ・プロテイナーゼ活性化受容体2の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・プロテイナーゼ活性化受容体2の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・プロテイナーゼ活性化受容体2のセグメント分析（種類別） （酢酸ララゾチド、AZ-8838、PZ-235、P-2pal18S、その他）...The global Proteinase Activated Receptor 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proteinase Activated Receptor 2 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Proteinase Activated Receptor 2 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Proteinase Activated Receptor 2 in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の組換え第VIII因子市場 2019年
    DATA909X14171 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換え第VIII因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、200IU、250IUに、用途別には、病院、薬局にセグメント区分し、組換え第VIII因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換え第VIII因子の世界市場概要 ・組換え第VIII因子の製造コスト構成分析 ・組換え第VIII因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換え第VIII因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換え第VIII因子のセグメント分析（種類別） （200IU、250IU）...The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Factor VIII market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Factor VIII in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の5ヒドロキシトリプタミン受容体遮断薬市場 2019年
    DATA909X02764 / QYResearch / 2019年11月22日 / ※本調査レポートは、5ヒドロキシトリプタミン受容体遮断薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、リセルグ酸誘導体、シプロヘプタジンに、用途別には、医療、科学研究、その他にセグメント区分し、5ヒドロキシトリプタミン受容体遮断薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・5ヒドロキシトリプタミン受容体遮断薬の世界市場概要 ・5ヒドロキシトリプタミン受容体遮断薬の製造コスト構成分析 ・5ヒドロキシトリプタミン受容体遮断薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・5ヒドロキシトリプタミン受容体遮断薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・5ヒドロキシトリプタミン受容体遮断薬のセグメント分析（種類別） （リセルグ酸誘導体、シプロヘプタジン）...The global 5 Hydroxytryptamine Receptor Blocker market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 5 Hydroxytryptamine Receptor Blocker volume and value at global level, regional level and company level. From a global perspective, this report represents overall 5 Hydroxytryptamine Receptor Blocker market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of 5 Hydroxytryptamine Receptor Blocker in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆